Literature DB >> 11263985

Activation-dependent surface expression of LOX-1 in human platelets.

M Chen1, M Kakutani, T Naruko, M Ueda, S Narumiya, T Masaki, T Sawamura.   

Abstract

Lectin-like oxidized LDL receptor-1 (LOX-1) was initially identified as an oxidized LDL receptor in aortic endothelial cells. Here we identified LOX-1 mRNA and protein in human platelets in addition to recent findings on the expression in macrophages and smooth muscle cells. The presence of LOX-1 was further confirmed in the megakaryocytic cell lines. Flow cytometric analyses revealed that LOX-1 was exposed on the surface of platelets in an activation-dependent manner. Consistently, the activation-dependent binding of OxLDL to platelets was mostly inhibited by anti-LOX-1 antibody. Immunohistochemistry of the atherosclerotic plaque from a patient with unstable angina pectoris (UAP) revealed accumulation of LOX-1 protein at the site of thrombus. As LOX-1 recognizes and binds activated platelets, exposure of LOX-1 on activated platelets surface might assist thrombosis formation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263985     DOI: 10.1006/bbrc.2001.4516

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

Review 2.  LOX-1, a new marker of risk and prognosis in coronary artery disease?

Authors:  Valter Lubrano; Silvana Balzan
Journal:  Mol Cell Biochem       Date:  2013-08-11       Impact factor: 3.396

Review 3.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

Review 4.  Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.

Authors:  Sanjiv Singh; Avtar Singh Gautam
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

Review 5.  Platelet hyperreactivity, scavenger receptors and atherothrombosis.

Authors:  M Valiyaveettil; E A Podrez
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 6.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Authors:  Suowen Xu; Sayoko Ogura; Jiawei Chen; Peter J Little; Joel Moss; Peiqing Liu
Journal:  Cell Mol Life Sci       Date:  2012-11-03       Impact factor: 9.261

7.  Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation.

Authors:  Hua-Chen Chan; Liang-Yin Ke; Chih-Sheng Chu; An-Sheng Lee; Ming-Yi Shen; Miguel A Cruz; Jing-Fang Hsu; Kai-Hung Cheng; Hsiu-Chuan Bonnie Chan; Jonathan Lu; Wen-Ter Lai; Tatsuya Sawamura; Sheng-Hsiung Sheu; Jeng-Hsien Yen; Chu-Huang Chen
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

Review 8.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

9.  LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells.

Authors:  Jane E Murphy; Daryl Tacon; Philip R Tedbury; Jonathan M Hadden; Stuart Knowling; Tatsuya Sawamura; Michelle Peckham; Simon E V Phillips; John H Walker; Sreenivasan Ponnambalam
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 10.  Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis.

Authors:  Yu-Xiao Liu; Pei-Zhe Yuan; Jie-Hong Wu; Bo Hu
Journal:  J Mol Med (Berl)       Date:  2021-08-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.